21. Psoriasis in a cohort of patients with common variable immunodeficiency. (25th February 2019) Authors: Megna, M.; Pecoraro, A.; Balato, N.; Villani, A.; Crescenzi, L.; Balato, A.; Spadaro, G. Journal: British journal of dermatology Issue: Volume 180:Number 4(2019) Page Start: 935 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. PUVA and interferon α2b combined therapy for patients with mycosis fungoides at different stages of the disease: a seven‐year retrospective study in Russia. (5th September 2018) Authors: Olisova, O.Y.; Megna, M.; Grekova, E.V.; Zaslavsky, D.V.; Gorenkova, L.G.; Sidikov, A.A.; Timoshchuk, E.A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 2(2019) Page Start: e72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. QuantiFERON‐TB Gold conversion is not uncommon in patients with psoriasis undergoing anti‐tumour necrosis factor‐α therapy. (1st November 2020) Authors: Megna, M.; Ruggiero, A.; Ferrillo, M.; Fabbrocini, G. Journal: British journal of dermatology Issue: Volume 183:Number 5(2020) Page Start: 977 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. QuantiFERON‐TB Gold conversion is not uncommon in patients with psoriasis undergoing anti‐tumour necrosis factor‐α therapy. (26th August 2020) Authors: Megna, M.; Ruggiero, A.; Ferrillo, M.; Fabbrocini, G. Journal: British journal of dermatology Issue: Volume 183:Number 5(2020) Page Start: 977 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Real‐life effectiveness of biological drugs on psoriatic difficult‐to‐treat body regions: scalp, palmoplantar area and lower limbs. (26th June 2018) Authors: Megna, M.; Cirillo, T.; Balato, A.; Balato, N.; Gallo, L. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 1(2019) Page Start: e22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Real‐life efficacy and safety of secukinumab in elderly patients with psoriasis over a 2‐year period. (1st October 2020) Authors: Megna, M.; Camela, E.; Cinelli, E.; Fabbrocini, G. Journal: Clinical and experimental dermatology Issue: Volume 45:Number 7(2020) Page Start: 848 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Real‐life efficacy and safety of secukinumab in elderly patients with psoriasis over a 2‐year period. (2nd June 2020) Authors: Megna, M.; Camela, E.; Cinelli, E.; Fabbrocini, G. Journal: Clinical and experimental dermatology Issue: Volume 45:Number 7(2020) Page Start: 848 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Reply to "Psoriasis exacerbation after COVID‐19 vaccination: report of 14 cases from a single centre" by Sotiriou E et al. (27th September 2021) Authors: Megna, M.; Potestio, L.; Gallo, L.; Caiazzo, G.; Ruggiero, A.; Fabbrocini, G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 1(2022) Page Start: e11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Reply to 'Development of severe pemphigus vulgaris following SARS‐CoV‐2 vaccination with BNT162b2' by Solimani et al. (17th June 2022) Authors: Martora, F.; Fabbrocini, G.; Nappa, P.; Megna, M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 10(2022) Page Start: e750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Secukinumab during pregnancy: a case report and review of literature. (2nd January 2022) Authors: Gallo, L.; Ruggiero, A.; Balato, A.; Megna, M.; Fabbrocini, G. Journal: Journal of dermatological treatment Issue: Volume 33:Number 1(2022) Page Start: 585 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗